PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsAmmonia n-13
Ammonia n-13
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
101 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Inborn urea cycle disordersD056806E72.2132611
Coronary artery diseaseD003324I25.111158
Heart diseasesD006331EFO_0003777I51.91124
Dental cariesD003731EFO_0003819K02134
Pulmonary hypertensionD006976EFO_0001361I27.201113
Myocardial ischemiaD017202EFO_1001375I20-I25112
Heart failureD006333EFO_0003144I5011
Pulmonary arterial hypertensionD00008102911
Familial primary pulmonary hypertensionD065627I27.011
Prostatic neoplasmsD011471C6111
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Brain diseasesD001927G93.40411015
Hepatic encephalopathyD006501K72.91311014
FibrosisD00535531912
HyperammonemiaD022124E72.20212
Portal hypertensionD006975EFO_0000666K76.61112
HyperargininemiaD020162Orphanet_90E72.2122
AscitesD001201R181112
Breast neoplasmsD001943EFO_0003869C5011
Inborn errors metabolismD008661111
Heart arrestD006323EFO_0009492I4611
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver cirrhosisD008103EFO_0001422K74.011314
Liver failureD017093K72.93811
Hepatic insufficiencyD048550279
End stage liver diseaseD058625EFO_1001311K72.1167
Acute-on-chronic liver failureD065290167
Acute liver failureD017114246
Liver diseasesD008107EFO_0001421K70-K77134
Ornithine carbamoyltransferase deficiency diseaseD020163EFO_0007409E72.41134
HypertensionD006973EFO_0000537I10123
HepatitisD006505K75.9123
Show 9 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CardiomyopathiesD009202EFO_0000318I42123
Coronary diseaseD003327112
RecurrenceD01200811
CarcinomaD002277C80.011
Ovarian neoplasmsD010051EFO_0003893C5611
Ovarian epithelial carcinomaD00007721611
Sleep deprivationD012892F51.1211
Stress fracturesD015775M84.311
SleepD012890GO_003043111
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 105,817 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
74 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use